American Portfolios Advisors’s Inovio Pharmaceuticals INO Stock Holding History

American Portfolios Advisors’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25	Closed	-$1.5K	–	3621
2021 Q4	$1.5K	Hold	25	–	–	﹤0.01%	3242
2021 Q3	$2.15K	Hold	25	–	–	﹤0.01%	3139
2021 Q2	$2.78K	Hold	25	–	–	﹤0.01%	3046
2021 Q1	$2.78K	Buy	+25	New	+$3.29K	﹤0.01%	2898
2020 Q4	–	Sell	-25	Closed	-$3.48K	–	3041
2020 Q3	$3.48K	Hold	25	–	–	﹤0.01%	2415
2020 Q2	$8.09K	Hold	25	–	–	﹤0.01%	2018
2020 Q1	$2.23K	Buy	+25	New	+$1.54K	﹤0.01%	2360

Other funds holding INO

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Portfolios Advisors's INO Position: Q1 2022 in Review

American Portfolios Advisors sold out of Inovio Pharmaceuticals (INO) in Q1 2022, closing a stake of 25 shares — an estimated $1.5K sold.

American Portfolios Advisors first reported a position in INO in Q1 2020 and held it in 7 quarters. The position peaked at $8.09K in Q2 2020. 198 funds tracked by Wall St. Rank hold INO as of Q1 2022.

American Portfolios Advisors reported no remaining Inovio Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
American Portfolios Advisors sold 25 Inovio Pharmaceuticals shares in Q1 2022, an estimated $1.5K.
American Portfolios Advisors first reported a position in Inovio Pharmaceuticals in Q1 2020 and held it in 7 quarters.
American Portfolios Advisors's Inovio Pharmaceuticals position peaked at $8.09K in Q2 2020.
198 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2022.

Based on American Portfolios Advisors's 13F filing for Q1 2022, filed 21 Mar 2023.